Overview

A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A study to assess efficacy, safety and pharmacokinetics of a tacrolimus new oral formulation (MR4) in de novo bone marrow transplant recipients
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Tacrolimus